drugset / Trial / NCT07226349
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Non-randomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of BG-75098 alone and in combination with BGB-43395 and fulvestrant in participants with advanced solid tumors.
Timeline
- Start
- 2025-12-11
- Primary completion
- 2028-11-01
- Completion
- 2028-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BG-75098 | Unknown | — | Oral |
| Subject | BGB-43395 | Unknown | — | Oral |
| Subject | Fulvestrant | Small molecule | — | Intramuscular |